Cargando…

Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia

BACKGROUND: Proton-pump inhibitors (PPIs) are commonly used in clinical practice for gastric acid suppression. However, these agents have also been associated with certain negative clinical outcomes. We evaluated the real-world effects of incident PPI use on clinical outcomes in patients with Staphy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caffrey, Aisling R., Timbrook, Tristan T., Ali, Syed Raza, Nizet, Victor, Sakoulas, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431768/ https://www.ncbi.nlm.nih.gov/pubmed/30923573 http://dx.doi.org/10.1177/1756284819834273

Ejemplares similares

264. Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with Staphylococcus aureus Bacteremia
por: Caffrey, Aisling, et al.
Publicado: (2020)

637. Β-Lactam (BL) Antibiotics Promote an IL-1β Response in Patients with Staphylococcus aureus Bacteremia (SaB)
por: Volk, Cecilia, et al.
Publicado: (2018)

Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia
por: Sakoulas, George, et al.
Publicado: (2016)

217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)

Impact of Vancomycin-Associated Acute Kidney Injury on Patient Outcomes in MRSA Bacteremia
por: Luther, Megan, et al.
Publicado: (2017)

255. Ticagrelor Aids Platelet-Mediated Clearance in a Refractory Staphylococcus aureus Endovascular Infection with Septic Emboli
por: Ulloa, Erlinda, et al.
Publicado: (2020)

Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Geriak, Matthew, et al.
Publicado: (2019)

Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii
por: Sakoulas, George, et al.
Publicado: (2017)

2243. Using Host Biomarkers and Time to Blood Culture Positivity to Predict Necessity for Echocardiogram in Patients with Staphylococcus aureus Endocarditis
por: Edwardson, Graham, et al.
Publicado: (2019)

1067. Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/Tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Beganovic, Maya, et al.
Publicado: (2018)

Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Schwaber, Mitchell J., et al.
Publicado: (2003)

Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus
por: Quach, D.T., et al.
Publicado: (2016)

Novel Bacterial Metabolite Merochlorin A Demonstrates in vitro Activity against Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus
por: Sakoulas, George, et al.
Publicado: (2012)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

Staphylococcus aureus Bacteremia, Australia
por: Collignon, Peter, et al.
Publicado: (2005)

Staphylococcus aureus Bacteremia, Europe
por: Tiemersma, Edine W., et al.
Publicado: (2005)

412. Host Response Biomarkers Predict Clinical Failure in Patients with Staphylococcus aureus Bacteremia (SAB) Treated with Flucloxacillin (FLU) or Vancomycin (VAN)
por: Aycock, Anna, et al.
Publicado: (2019)

Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus
por: Kumaraswamy, Monika, et al.
Publicado: (2021)

Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus
por: Machado, Henrique, et al.
Publicado: (2021)

Genetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus
por: Salazar, Michael J., et al.
Publicado: (2020)

Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study
por: Schweizer, Marin L., et al.
Publicado: (2010)

Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors
por: Rampacci, Elisa, et al.
Publicado: (2023)

Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus
por: Haste, Nina M., et al.
Publicado: (2012)

Vascular Proteome Responses Precede Organ Dysfunction in a Murine Model of Staphylococcus aureus Bacteremia
por: Sorrentino, James T., et al.
Publicado: (2022)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Dey, Somrita, et al.
Publicado: (2019)

Staphylococcus aureus Prostatic Abscess in the Setting of Prolonged S. aureus Bacteremia
por: Eichenberger, Emily M., et al.
Publicado: (2020)

Echocardiography Is Dispensable in Uncomplicated Staphylococcus aureus Bacteremia
por: Khatib, Riad, et al.
Publicado: (2013)

Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Choo, Eun Ju, et al.
Publicado: (2016)

672 Staphylococcus aureus Bacteremia in Hospitalized Children
por: Klieger, Sarah B., et al.
Publicado: (2014)

Epidemiology of Community-Onset Staphylococcus aureus Bacteremia
por: Yarovoy, James Y., et al.
Publicado: (2019)

Antiplatelet therapy for Staphylococcus aureus bacteremia: Will it stick?
por: Tatara, Alexander M., et al.
Publicado: (2022)

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023)

227. Staphylococcus aureus bacteremia: back to normal
por: Pedromingo Kus, Miguel Sebastian, et al.
Publicado: (2023)

Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapy
por: Dhand, Abhay, et al.
Publicado: (2012)

Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis
por: Gilbertie, Jessica, et al.
Publicado: (2022)

Do Proton Pump Inhibitors Decrease Calcium Absorption?
por: Hansen, Karen E, et al.
Publicado: (2010)

A Narrative Review on the Role of Staphylococcus aureus Bacteriuria in S. aureus Bacteremia
por: Schuler, Franziska, et al.
Publicado: (2021)

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
por: McCreary, Erin K, et al.
Publicado: (2019)

Improved survival with continuation of statins in bacteremic patients
por: Pawar, Ajinkya M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_36762s070gvr6ovlb10jkofgge